Sanofi SA said late on Wednesday that the European Commission has granted a marketing authorization for Supemtek. "Sanofi's Influenza Vaccine Gets European Commission Approval," at 0701 GMT, incorrectly said the statement was from Thursday.

 

(END) Dow Jones Newswires

November 19, 2020 02:56 ET (07:56 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Sanofi (EU:SAN)
過去 株価チャート
から 3 2024 まで 4 2024 Sanofiのチャートをもっと見るにはこちらをクリック
Sanofi (EU:SAN)
過去 株価チャート
から 4 2023 まで 4 2024 Sanofiのチャートをもっと見るにはこちらをクリック